First-in-Human Trial Uses Laser Light to Attack Inoperable Pancreatic Tumors
A first-in-human phase 1 trial at UCI Health is using padeliporfin vascular-targeted photodynamic therapy to destroy pancreatic tumors encasing major ...
A first-in-human phase 1 trial at UCI Health is using padeliporfin vascular-targeted photodynamic therapy to destroy pancreatic tumors encasing major ...
A retrospective German cohort study found men with extremity leiomyosarcoma had markedly higher rates of incomplete initial resection, outside-center first ...
A new review shows that intraoperative radionuclide imaging techniques, including Cerenkov luminescence imaging, flexible autoradiography, and mobile PET/CT, can detect ...
A recurrent basal cell carcinoma case from Japan reveals how deep subcutaneous tumor growth and superficial lateral microextension can evade ...
Surgeons report the first documented case of a dog returning to normal activity after complete removal of the lumbar epaxial ...
A new commentary argues that lung nodule localisation is entering a precision era, as stabilised fluorescent matrices aim to solve ...
A new survey of American College of Mohs Surgery members finds that while most surgeons expect artificial intelligence to reshape ...
A propensity score-matched study of 153 patients suggests adjuvant radiotherapy does not improve overall or recurrence-free survival in limb liposarcoma, ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.